PIPA521151

RASSF10 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA521151-Each-of-1 In Stock ₹ 46,502.50

PIPA521151 - Each of 1

₹ 46,502.50

In Stock

Quantity

1

Base Price: ₹ 46,502.50

GST (18%): ₹ 8,370.45

Total Price: ₹ 54,872.95

Antigen

RASSF10

Classification

Polyclonal

Conjugate

Unconjugated

Gene

RASSF10

Gene Alias

4632411J06Rik; Ras association (RalGDS/AF-6) domain family (N-terminal) member 10; Ras association domain family member 10; ras association domain-containing protein 10; Rassf10

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

644943

Content And Storage

4° C

Form

Liquid

Applications

Immunohistochemistry, Western Blot

Concentration

1 mg/mL

Formulation

PBS with 0.02% sodium azide

Gene Accession No.

A6NK89

Gene Symbols

RASSF10

Immunogen

A 17 amino acid peptide near the amino terminus of human RASSF10.

Quantity

100 μg

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA521160

--

Img

Thermo Scientific

PIPA521083

--

Img

Thermo Scientific

PIPA520983

--

Img

Thermo Scientific

PIPA520924

--

Img

Thermo Scientific

PIPA521173

--

Img

Thermo Scientific

PIPA521123

--

Img

Thermo Scientific

PIPA521095

--

Img

Thermo Scientific

PIPA520780

--

Description

  • A suggested positive control is human lung tissue lysate
  • PA5-21151 can be used with blocking peptide PEP-1265
  • RASSF10 is a member of the N-terminal Ras association domain-containing family of proteins, a family of tumor suppressor genes that are frequently epigenetically inactivated in cancer
  • These proteins consist of RASSF7-10 and are structurally distinct from RASSF1-6, containing the N-terminal Ras association domain but lacking the Sav/RASSF/Hippo protein interaction domains
  • While little is known of the function of RASSF10, it is inactivated in both childhood leukemia and gliomas
  • In secondary glioblastomas, RASSF10 methylation can be used as an independent prognostic associated with worst progression-free survival and overall survival.